4 free views remaining today
retinitis pigmentosa 74
ICD-10 Codes
Related ICD-10:
Description
Retinitis Pigmentosa (RP): A Group of Genetic Disorders
Retinitis pigmentosa, also known as RP, is a group of genetic disorders that affect the retina's ability to respond to light, causing a slow loss of vision [1]. This condition is characterized by progressive deterioration of the retina, leading to visual problems and eventual blindness [8].
Causes and Symptoms
RP is an inherited disorder, meaning it is passed down from parents to their children through genes. The symptoms of RP can vary depending on the individual, but common signs include trouble with night vision, irregular retina pigmentation, and a slow decline in eyesight [2][3]. As the condition progresses, people with RP may experience loss of peripheral vision and eventually complete blindness [7].
Types and Variations
RP is a clinically and genetically heterogeneous group of inherited retinal disorders, meaning that it can manifest differently in different individuals [6]. The condition often leads to legal and sometimes complete blindness, making it essential for early detection and treatment.
References:
[1] Context result 1 [2] Context result 2 [3] Context result 3 [6] Context result 6 [7] Context result 7 [8] Context result 8
Additional Characteristics
- a group of genetic disorders
- a clinically and genetically heterogeneous group of inherited retinal disorders
- an inherited disorder
Signs and Symptoms
Common Signs and Symptoms of Retinitis Pigmentosa
Retinitis pigmentosa (RP) is a group of rare eye diseases that affect the retina, leading to progressive vision loss. The signs and symptoms of RP can vary from person to person, but here are some common ones:
- Night blindness: This is often the first sign of RP, where individuals have difficulty seeing in dim light or at dusk.
- Trouble adjusting to light changes: People with RP may struggle to adjust their vision when moving from bright to dim light or vice versa.
- Difficulty seeing in bad weather: Cloudy or foggy conditions can make it harder for people with RP to see.
- Tunnel vision: As the disease progresses, individuals may experience tunnel vision, where they can only see a narrow field of vision.
- Sensitivity to bright light: Some people with RP may be uncomfortable or sensitive to bright light (photophobia).
- Loss of color vision: In advanced stages of RP, individuals may lose their ability to see colors.
- Very low vision: Eventually, most people with RP will experience significant vision loss.
These symptoms can develop gradually over time and may start in childhood. The progression and severity of the disease vary from person to person, but early detection and treatment can help manage the condition.
References:
- [1] Symptoms usually start in childhood, and most people eventually lose most of their sight.
- [3] Retinitis pigmentosa causes a slow decline in eyesight and the field of vision.
- [5] Loss of night vision is when you cannot see anything in the dark.
- [6] Night vision may eventually be lost.
- [7] RP usually begins as night or dim light visual impairment.
- [8] Trouble adjusting to light changes or dim lighting.
- [11] Retinitis pigmentosa usually starts in childhood.
Additional Symptoms
- Night blindness
- Tunnel vision
- Loss of color vision
- Trouble adjusting to light changes
- Difficulty seeing in bad weather
- Sensitivity to bright light (photophobia)
- Very low vision
Diagnostic Tests
Diagnostic Tests for Retinitis Pigmentosa
Retinitis pigmentosa (RP) is a group of inherited eye diseases that affect the retina, and diagnostic tests play a crucial role in its diagnosis. Here are some common diagnostic tests used to investigate RP:
- Electro-diagnostic tests: These tests include electroretinogram (ERG), electro-oculogram (EOG), and multifocal electroretinogram (mfERG). They provide an objective measure of rod and cone function across the retina [3].
- Genetic testing: This test looks at a sample of your blood or other tissues to see if you have certain genes that are associated with RP. Genetic testing can identify specific genetic mutations that cause RP, such as the RPE65 gene mutation [4].
- Electroretinogram (ERG): ERG is the most critical diagnostic test for RP because it provides an objective measure of rod and cone function across the retina [3]. It helps confirm the diagnosis by demonstrating attenuated rod and cone signals [8].
- Optical Coherence Tomography (OCT) scan: An OCT scan can show loss of photoreceptors in the retina, which is a common finding in RP patients [6].
These diagnostic tests help healthcare professionals diagnose RP and rule out other conditions that may cause similar symptoms. Early diagnosis and genetic testing can also provide valuable information for family planning and genetic counseling.
References: [3] May 16, 2024 — Electroretinogram. [4] Nov 11, 2024 — Genetic testing. [6] The diagnosis of RP is based on peripheral visual field loss, pigment deposits in fundus, loss of photoreceptors at the OCT scan ... [8] Sep 21, 2023 — Electroretinograms help confirm the diagnosis by demonstrating attenuated rod and cone signals.
Additional Diagnostic Tests
- Genetic testing
- Electroretinogram (ERG)
- Electro-diagnostic tests
- Optical Coherence Tomography (OCT) scan
Treatment
Current Drug Treatments for Retinitis Pigmentosa
While there are no curative treatments available for retinitis pigmentosa (RP), several medications have shown promise in slowing down the progression of the disease or improving visual function. Here are some of the current drug treatments being explored:
- Luxturna: This is a gene therapy product approved by the FDA to treat a specific type of RP caused by mutations in the RPE65 gene. It works by delivering a healthy copy of the gene to retinal cells, allowing them to produce a functional protein [1].
- QR-421a: This is an experimental therapy that has shown promise in improving visual function in patients with RP. It involves injecting a healthy version of the USH2A protein into the retina, which helps to slow down the progression of the disease [2].
- Acetazolamide: Studies have shown that oral acetazolamide can improve visual function in some patients with RP. This medication works by reducing fluid buildup in the retina and improving retinal function [5].
Emerging Therapies
Researchers are also exploring new therapies to treat RP, including:
- N-acetylcysteine (NAC): A Phase 3 clinical trial is currently underway at Johns Hopkins University to investigate the use of NAC for treating RP [7].
- Gene therapy: New research suggests that a type of gene therapy can improve vision in people who have lost nearly all sight to RP [9].
Other Treatments
In addition to these specific treatments, some patients with RP may also benefit from:
- Vitamins and supplements: Certain vitamins and supplements, such as vitamin A, E, and C, may help to slow down the progression of RP.
- Fat-soluble vitamins: These vitamins are essential for maintaining healthy retinal cells and may be beneficial in treating RP [3].
- Calcium channel blockers: Some studies have suggested that these medications may also be beneficial in slowing down the progression of RP.
It's essential to note that each patient with RP is unique, and what works for one person may not work for another. A healthcare professional can help determine the best course of treatment for an individual case.
References:
[1] Cross N (2022) - Currently, Luxturna is the only approved therapy for RP...
[2] Aug 16, 2021 - The therapy, called QR-421a, is injected into the retina and allows cells to produce a healthier version of the USH2A protein.
[3] May 16, 2024 - Retinitis Pigmentosa Medication: Vitamins, Fat-Soluble, Calcium channel blockers...
[5] May 16, 2024 - Of the many therapies tried, oral acetazolamide has shown the most encouraging results with some improvement in visual function.
[7] Oct 7, 2024 - Johns Hopkins University (JHU) has launched a Phase 3 clinical trial of N-acetylcysteine (NAC) for the treatment of retinitis pigmentosa (RP).
[9] Oct 20, 2024 - New research suggests that a new kind of gene therapy can improve vision in people who have lost nearly all sight to retinitis pigmentosa.
Recommended Medications
- Luxturna
- Gene therapy
- Vitamins and supplements
- Calcium channel blockers
- N-acetylcysteine (NAC)
- QR-421a
- Fat-soluble vitamins
- acetazolamide
- Acetazolamide
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
The differential diagnosis of retinitis pigmentosa (RP) involves identifying other conditions that may present with similar symptoms, making it essential to rule out these possibilities before confirming a diagnosis of RP.
According to various sources [3][9][11][12], the differential diagnoses for RP include:
- Leber's congenital amaurosis (LCA), which is a group of inherited eye disorders characterized by severe visual impairment or blindness from birth
- Myotonic dystrophy-associated retinopathy, which is a condition that affects the retina and can cause vision problems
- Infectious diseases such as syphilis or congenital rubella, which can affect the eyes and cause similar symptoms to RP
- Drug-induced retinal degeneration, which can be caused by certain medications such as chloroquine
Other conditions that may be considered in the differential diagnosis of RP include:
- Unilateral retinal pigment epithelium changes and peripheral field loss with preserved central vision [8]
- Concentric retinitis pigmentosa (RP), a rare form of RP where retinal degeneration is limited to the periphery [5]
It's worth noting that individuals who present with initial symptoms such as photopsia, abnormal central vision, abnormal color vision, or marked asymmetry in ocular involvement may not have RP, but another retinal degeneration or retinal disease [11].
The diagnosis of RP is based on a combination of clinical findings, including peripheral visual field loss, pigment deposits in the fundus, and loss of photoreceptors at the optical coherence tomography (OCT) scan [7]. However, it's essential to consider these differential diagnoses when evaluating patients with suspected RP.
References: [3] Boyd K, Vemulakonda GA, Turbert D. Retinitis Pigmentosa. American Academy of Ophthalmology. [5] by M Nakahara · 2021 · C
Additional Differential Diagnoses
- Myotonic dystrophy-associated retinopathy
- Leber's congenital amaurosis (LCA)
- Infectious diseases such as syphilis or congenital rubella
- Drug-induced retinal degeneration
- Unilateral retinitis pigment epithelium changes and peripheral field loss with preserved central vision
- Concentric retinitis pigmentosa (RP)
- retinal degeneration
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_4755
- owl#annotatedSource
- t366074
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#hasDbXref
- MIM:616562
- oboInOwl#id
- DOID:0110401
- core#notation
- DOID:0110401
- IAO_0000115
- A retinitis pigmentosa that has_material_basis_in mutation in the BBS2 gene on chromosome 16q13.
- rdf-schema#label
- retinitis pigmentosa 74
- oboInOwl#hasExactSynonym
- RP74
- rdf-schema#subClassOf
- t365991
- IDO_0000664
- http://purl.obolibrary.org/obo/GENO_0000148
- relatedICD
- http://example.org/icd10/H35.5
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.